Who watches the watchmen? Regulation of the expression and activity of sirtuins

FASEB Journal

Volumn 30, Issue 12, 2016, Pages 3942-3960

  Buler, Marcin ^a   Andersson, Ulf ^a   Hakkola, Jukka ^b,c  

^a ASTRAZENECA R AND D   (Sweden)

^b UNIVERSITY OF OULU   (Finland)

^c OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Deacetylation; MiRNA; Post translational modification; SIRT; Transcriptional regulation

Indexed keywords

MICRORNA; SIRTUIN; SIRTUIN 1; SIRTUIN 2; SIRTUIN 3; SIRTUIN 4; SIRTUIN 5; SIRTUIN 6; SIRTUIN 7; NICOTINAMIDE ADENINE DINUCLEOTIDE;

ARTICLE; CELL FUNCTION; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROCESSING; TRANSCRIPTION REGULATION; AGING; ANIMAL; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY;

AGING; ANIMALS; HUMANS; MICRORNAS; NAD; OXIDATIVE STRESS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIRTUINS;

EID: 85002376289     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.201600410RR     Document Type: Article

References (240)

1. Imai, S., Armstrong, C.M., Kaeberlein, M., and Guarente, L. (2000) Transcriptional silencing and longevity protein Sir2 is an NADdependent histone deacetylase. Nature 403, 795-800
2. Tan, M., Peng, C., Anderson, K. A., Chhoy, P., Xie, Z., Dai, L., Park, J., Chen, Y., Huang, H., Zhang, Y., Ro, J., Wagner, G. R., Green, M. F., Madsen, A. S., Schmiesing, J., Peterson, B. S., Xu, G., Ilkayeva, O. R., Muehlbauer, M. J., Braulke, T., Mühlhausen, C., Backos, D. S., Olsen, C. A., McGuire, P. J., Pletcher, S. D., Lombard, D. B., Hirschey, M. D., and Zhao, Y. (2014) Lysine glutarylation is a protein posttranslational modification regulated by SIRT5. Cell Metab. 19, 605-617
3. Du, J., Zhou, Y., Su, X., Yu, J. J., Khan, S., Jiang, H., Kim, J., Woo, J., Kim, J. H., Choi, B. H., He, B., Chen, W., Zhang, S., Cerione, R. A., Auwerx, J., Hao, Q., and Lin, H. (2011) Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 334, 806-809
4. Bao, X., Wang, Y., Li, X., Li, X.-M., Liu, Z., Yang, T., Wong, C. F., Zhang, J., Hao, Q., and Li, X.D. (2014) Identification of 'erasers' for lysine crotonylated histone marks using a chemical proteomics approach. eLife 3, 3
5. Kumar, S., and Lombard, D. B. (2015) Mitochondrial sirtuins and their relationships with metabolic disease and cancer. Antioxid. Redox Signal. 22, 1060-1077
6. Trapp, J., and Jung, M. (2006) The role of NAD+ dependent histone deacetylases (sirtuins) in ageing. Curr. Drug Targets 7, 1553-1560
7. Kaeberlein, M., McVey, M., and Guarente, L. (1999) The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev. 13, 2570-2580
8. Wątroba, M., and Szukiewicz, D. (2016) The role of sirtuins in aging and age-related diseases. Adv. Med. Sci. 61, 52-62
9. Shi, T., Wang, F., Stieren, E., and Tong, Q. (2005) SIRT3, a mitochondrial sirtuin deacetylase, regulatesmitochondrial function and thermogenesis in brown adipocytes. J. Biol. Chem. 280, 13560-13567
10. Sidorova-Darmos, E., Wither, R. G., Shulyakova, N., Fisher, C., Ratnam, M., Aarts, M., Lilge, L., Monnier, P. P., and Eubanks, J. H. (2014) Differential expression of sirtuin family members in the developing, adult, and aged rat brain. Front. Aging Neurosci. 6, 333
11. Ruggieri, S., Orsomando, G., Sorci, L., and Raffaelli, N. (2015) Regulation of NAD biosynthetic enzymes modulates NAD-sensing processes to shape mammalian cell physiology under varying biological cues. Biochim. Biophys. Acta 1854, 1138-1149
12. Opitz, C. A., and Heiland, I. (2015) Dynamics of NAD-metabolism: everything but constant. Biochem. Soc. Trans. 43, 1127-1132
13. + in aging, metabolism, and neurodegeneration. Science 350, 1208-1213
14. Hebert, A. S., Dittenhafer-Reed, K. E., Yu, W., Bailey, D. J., Selen, E.S., Boersma, M.D., Carson, J. J., Tonelli, M., Balloon, A. J., Higbee, A. J., Westphall, M. S., Pagliarini, D. J., Prolla, T. A., Assadi-Porter, F., Roy, S., Denu, J. M., and Coon, J. J. (2013) Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome. Mol. Cell 49, 186-199
15. Rardin, M. J., He, W., Nishida, Y., Newman, J. C., Carrico, C., Danielson, S.R., Guo, A., Gut, P., Sahu, A.K., Li, B., Uppala, R., Fitch, M., Riiff, T., Zhu, L., Zhou, J., Mulhern, D., Stevens, R. D., Ilkayeva, O. R., Newgard, C. B., Jacobson, M. P., Hellerstein, M., Goetzman, E. S., Gibson, B. W., and Verdin, E. (2013) SIRT5 regulates the mitochondrial lysine succinylome and metabolic networks. Cell Metab. 18, 920-933
16. Tanno, M., Sakamoto, J., Miura, T., Shimamoto, K., and Horio, Y. (2007) Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1. J. Biol. Chem. 282, 6823-6832
17. Perrod, S., Cockell, M. M., Laroche, T., Renauld, H., Ducrest, A. L., Bonnard, C., and Gasser, S. M. (2001) A cytosolic NAD-dependent deacetylase, Hst2p, canmodulate nucleolar and telomeric silencing in yeast. EMBO J. 20, 197-209
18. Vaquero, A., Scher, M. B., Lee, D. H., Sutton, A., Cheng, H. L., Alt, F. W., Serrano, L., Sternglanz, R., and Reinberg, D. (2006) SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis. Genes Dev. 20, 1256-1261
19. Onyango, P., Celic, I., McCaffery, J. M., Boeke, J. D., and Feinberg, A. P. (2002) SIRT3, a human SIR2 homologue, is an NADdependent deacetylase localized to mitochondria. Proc. Natl. Acad. Sci. USA 99, 13653-13658
20. Iwahara, T., Bonasio, R., Narendra, V., and Reinberg, D. (2012) SIRT3 functions in the nucleus in the control of stress-related gene expression. Mol. Cell. Biol. 32, 5022-5034
21. Michishita, E., Park, J. Y., Burneskis, J. M., Barrett, J. C., and Horikawa, I. (2005) Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol. Biol. Cell 16, 4623-4635
22. Matsushita, N., Yonashiro, R., Ogata, Y., Sugiura, A., Nagashima, S., Fukuda, T., Inatome, R., and Yanagi, S. (2011) Distinct regulation of mitochondrial localization and stability of two human Sirt5 isoforms. Genes Cells 16, 190-202
23. Jiang, H., Khan, S., Wang, Y., Charron, G., He, B., Sebastian, C., Du, J., Kim, R., Ge, E., Mostoslavsky, R., Hang, H.C., Hao, Q., and Lin, H. (2013) SIRT6 regulates TNF-α secretion through hydrolysis of longchain fatty acyl lysine. Nature 496, 110-113
24. Mostoslavsky, R., Chua, K. F., Lombard, D. B., Pang, W.W., Fischer, M.R., Gellon, L., Liu, P., Mostoslavsky, G., Franco, S., Murphy, M.M., Mills, K. D., Patel, P., Hsu, J. T., Hong, A. L., Ford, E., Cheng, H. L., Kennedy, C., Nunez, N., Bronson, R., Frendewey, D., Auerbach, W., Valenzuela, D., Karow, M., Hottiger, M.O., Hursting, S., Barrett, J.C., Guarente, L., Mulligan, R., Demple, B., Yancopoulos, G.D., and Alt, F. W. (2006) Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 124, 315-329
25. Ford, E., Voit, R., Liszt, G., Magin, C., Grummt, I., and Guarente, L. (2006) Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription. Genes Dev. 20, 1075-1080
26. Poulose, N., and Raju, R. (2015) Sirtuin regulation in aging and injury. Biochim. Biophys. Acta 1852, 2442-2455
27. Haigis, M. C., and Sinclair, D. A. (2010) Mammalian sirtuins: biological insights and disease relevance. Annu. Rev. Pathol. 5, 253-295
28. Lin, Z., and Fang, D. (2013) The roles of SIRT1 in cancer. Genes Cancer 4, 97-104
29. Cao, Y., Jiang, X., Ma, H., Wang, Y., Xue, P., and Liu, Y. (2016) SIRT1 and insulin resistance. J. Diabetes Complications 30, 178-183
30. Matsushima, S., and Sadoshima, J. (2015) The role of sirtuins in cardiac disease. Am. J. Physiol. Heart Circ. Physiol. 309, H1375-H1389
31. Kilic, U., Gok, O., Bacaksiz, A., Izmirli, M., Elibol-Can, B., and Uysal, O. (2014) SIRT1 gene polymorphisms affect the protein expression in cardiovascular diseases. PLoS One 9, e90428
32. Rai, E., Sharma, S., Kaul, S., Jain, K., Matharoo, K., Bhanwer, A. S., and Bamezai, R. N. K. (2012) The interactive effect of SIRT1 promoter region polymorphism on type 2 diabetes susceptibility in the North Indian population. PLoS One 7, e48621
33. Zhang, A., Wang, H., Qin, X., Pang, S., and Yan, B. (2012) Genetic analysis of SIRT1 gene promoter in sporadic Parkinson's disease. Biochem. Biophys. Res. Commun. 422, 693-696
34. Consiglio, C. R., Juliana da Silveira, S., Monticielo, O. A., Xavier, R. M., Brenol, J. C. T., and Chies, J. A. B. (2014) SIRT1 promoter polymorphisms as clinical modifiers on systemic lupus erythematosus. Mol. Biol. Rep. 41, 4233-4239
35. Han, Q., Zhang, Y., Li, W., Fan, H., Xing, Q., Pang, S., and Yan, B. (2014) Functional sequence variants within the SIRT1 gene promoter in indirect inguinal hernia. Gene 546, 1-5
36. Noriega, L. G., Feige, J. N., Canto, C., Yamamoto, H., Yu, J., Herman, M. A., Mataki, C., Kahn, B. B., and Auwerx, J. (2011) CREB and ChREBPoppositely regulate SIRT1 expressioninresponse toenergy availability. EMBO Rep. 12, 1069-1076
37. Hayashida, S., Arimoto, A., Kuramoto, Y., Kozako, T., Honda, S., Shimeno, H., and Soeda, S. (2010) Fasting promotes the expression of SIRT1, an NAD+ -dependent protein deacetylase, via activation of PPARalpha in mice. Mol. Cell. Biochem. 339, 285-292
38. Okazaki, M., Iwasaki, Y., Nishiyama, M., Taguchi, T., Tsugita, M., Nakayama, S., Kambayashi, M., Hashimoto, K., and Terada, Y. (2010) PPARbeta/delta regulates the human SIRT1 gene transcription via Sp1. Endocr. J. 57, 403-413
39. Han, L., Zhou, R., Niu, J., McNutt, M. A., Wang, P., and Tong, T. (2010) SIRT1 is regulated by a PPARγ-SIRT1negative feedback loop associated with senescence. Nucleic Acids Res. 38, 7458-7471
40. Yang, S. J., Choi, J.M., Chang, E., Park, S.W., and Park, C.-Y. (2014) Sirt1 and Sirt6mediate beneficial effects of rosiglitazone on hepatic lipid accumulation. PLoS One 9, e105456
41. Xiong, S., Salazar, G., Patrushev, N., and Alexander, R. W. (2011) FoxO1 mediates an auto feedback loop regulating SIRT1 expression. J. Biol. Chem. 286, 5289-5299
42. Daitoku, H., Hatta, M., Matsuzaki, H., Aratani, S., Ohshima, T., Miyagishi, M., Nakajima, T., and Fukamizu, A. (2004) Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proc. Natl. Acad. Sci. USA 101, 10042-10047
43. Nemoto, S., Fergusson, M. M., and Finkel, T. (2004) Nutrient availability regulates SIRT1 through a forkhead-dependent pathway. Science 306, 2105-2108
44. Jin, J., Iakova, P., Jiang, Y., Medrano, E. E., and Timchenko, N. A. (2011) Thereduction of SIRT1in livers of oldmice leads toimpaired body homeostasis and to inhibition of liver proliferation. Hepatology 54, 989-998
45. Jin, Q., Zhang, F., Yan, T., Liu, Z., Wang, C., Ge, X., and Zhai, Q. (2010) C/EBPalpha regulates SIRT1 expression during adipogenesis. Cell Res. 20, 470-479
46. Zhou, B., Zhang, Y., Zhang, F., Xia, Y., Liu, J., Huang, R., Wang, Y., Hu, Y., Wu, J., Dai, C., Wang, H., Tu, Y., Peng, X., Wang, Y., and Zhai, Q. (2014) CLOCK/BMAL1 regulates circadian change of mouse hepatic insulin sensitivity by SIRT1. Hepatology 59, 2196-2206
47. Luo, J., Nikolaev, A. Y., Imai, S., Chen, D., Su, F., Shiloh, A., Guarente, L., and Gu, W. (2001) Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107, 137-148
48. Brunet, A., Sweeney, L. B., Sturgill, J.F., Chua, K. F., Greer, P. L., Lin, Y., Tran, H., Ross, S. E., Mostoslavsky, R., Cohen, H. Y., Hu, L. S., Cheng, H.-L., Jedrychowski, M. P., Gygi, S. P., Sinclair, D. A., Alt, F.W., and Greenberg, M. E. (2004) Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303, 2011-2015
49. Katto, J., Engel, N., Abbas, W., Herbein, G., and Mahlknecht, U. (2013) Transcription factor NFκB regulates the expression of the histone deacetylase SIRT1. Clin. Epigenetics 5, 11
50. Zhang, H.-N., Li, L., Gao, P., Chen, H.-Z., Zhang, R., Wei, Y.-S., Liu, D.-P., and Liang, C.-C. (2010) Involvement of the p65/RelA subunit of NF-kappaB in TNF-alpha-induced SIRT1 expression in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 397, 569-575
51. Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., and Mayo, M. W. (2004) Modulation of NF-kappaB dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 23, 2369-2380
52. Wang, P.-X., Zhang, R., Huang, L., Zhu, L.-H., Jiang, D.-S., Chen, H.-Z., Zhang, Y., Tian, S., Zhang, X.-F., Zhang, X.-D., Liu, D.-P., and Li, H. (2015) Interferon regulatory factor 9 is a key mediator of hepatic ischemia/reperfusion injury. J. Hepatol. 62, 111-120
53. Pardo, P. S., and Boriek, A.M. (2012) An autoregulatory loop reverts the mechanosensitive Sirt1 induction by EGR1 in skeletal muscle cells. Aging (Albany, N.Y.) 4, 456-461
54. Antoniali, G., Lirussi, L., D'Ambrosio, C., Dal Piaz, F., Vascotto, C., Casarano, E., Marasco, D., Scaloni, A., Fogolari, F., and Tell, G. (2014) SIRT1 gene expression upon genotoxic damage is regulated by APE1 through nCaRE-promoter elements. Mol. Biol. Cell 25, 532-547
55. Koga, T., Suico, M. A., Shimasaki, S., Watanabe, E., Kai, Y., Koyama, K., Omachi, K., Morino-Koga, S., Sato, T., Shuto, T., Mori, K., Hino, S., Nakao, M., and Kai, H. (2015) ERstress induces SIRT1 expression via the PI3K-Akt-GSK3β signaling pathway and promotes hepatocellular injury. J. Biol. Chem. 290, 30366-30374
56. Kwon, H.-S., and Ott, M. (2008) The ups and downs of SIRT1. Trends Biochem. Sci. 33, 517-525
57. Chen, W. Y., Wang, D.H., Yen, R. C., Luo, J., Gu, W., and Baylin, S. B. (2005) Tumor suppressor HIC1 directly regulates SIRT1 to modulatep53-dependent DNA-damage responses. Cell 123, 437-448
58. Lim, J.-H., Lee, Y.-M., Chun, Y.-S., Chen, J., Kim, J.-E., and Park, J.-W. (2010) Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Mol. Cell 38, 864-878
59. Sun, L., Li, H., Chen, J., Dehennaut, V., Zhao, Y., Yang, Y., Iwasaki, Y., Kahn-Perles, B., Leprince, D., Chen, Q., Shen, A., and Xu, Y. (2013) A SUMOylation-dependent pathway regulates SIRT1 transcription and lung cancer metastasis. J. Natl. Cancer Inst. 105, 887-898
60. Chen, R., Dioum, E. M., Hogg, R. T., Gerard, R. D., and Garcia, J.A. (2011) Hypoxia increases sirtuin1 expressionin ahypoxia-inducible factor-dependent manner. J. Biol. Chem. 286, 13869-13878
61. Wang, C., Chen, L., Hou, X., Li, Z., Kabra, N., Ma, Y., Nemoto, S., Finkel, T., Gu, W., Cress, W. D., and Chen, J. (2006) Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage. Nat. Cell Biol. 8, 1025-1031
62. Laine, A., and Westermarck, J. (2014) Molecular pathways: harnessing E2F1 regulation for prosenescence therapy in p53-defective cancer cells. Clin. Cancer Res. 20, 3644-3650
63. Zhu, G.-Y., Shi, B.-Z., and Li, Y. (2014) FoxM1 regulates Sirt1 expression in glioma cells. Eur. Rev. Med. Pharmacol. Sci. 18, 205-211
64. Zhu, H., Xia, L., Zhang, Y., Wang, H., Xu, W., Hu, H., Wang, J., Xin, J., Gang, Y., Sha, S., Xu, B., Fan, D., Nie, Y., and Wu, K. (2012) Activating transcription factor 4 confers a multidrug resistance phenotype to gastric cancer cells through transactivation of SIRT1 expression. PLoS One 7, e31431
65. Bartel, D. P. (2009) MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233
66. Inui, M., Martello, G., and Piccolo, S. (2010) MicroRNA control of signal transduction. Nat. Rev. Mol. Cell Biol. 11, 252-263
67. Yamakuchi, M. (2012) MicroRNA regulation of SIRT1. Front. Physiol. 3, 68
68. Saunders, L. R., Sharma, A. D., Tawney, J., Nakagawa, M., Okita, K., Yamanaka, S., Willenbring, H., and Verdin, E. (2010) miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissues. Aging (Albany, N.Y.) 2, 415-431
69. Qi, F., Hu, J.-F., Liu, B.-H., Wu, C.-Q., Yu, H.-Y., Yao, D.-K., and Zhu, L. (2015) MiR-9a-5p regulates proliferation and migration of hepatic stellate cells under pressure through inhibition of Sirt1. World J. Gastroenterol. 21, 9900-9915
70. Zhang, S., Zhang, D., Yi, C., Wang, Y., Wang, H., and Wang, J. (2015) MicroRNA-22 functions as a tumor suppressor by targeting SIRT1 in renal cell carcinoma. Oncol. Rep. 35, 559-567
71. Bae, H. J., Noh, J. H., Kim, J. K., Eun, J. W., Jung, K. H., Kim, M. G., Chang, Y. G., Shen, Q., Kim, S.-J., Park, W. S., Lee, J. Y., and Nam, S. W. (2014) MicroRNA-29c functions as a tumor suppressor by direct targeting oncogenic SIRT1 in hepatocellular carcinoma. Oncogene 33, 2557-2567
72. Li, N., Muthusamy, S., Liang, R., Sarojini, H., and Wang, E. (2011) Increased expression of miR-34a and miR-93 in rat liver during aging, and their impact on the expression of Mgst1 and Sirt1. Mech. Ageing Dev. 132, 75-85
73. Katsura, A., Morishita, A., Iwama, H., Tani, J., Sakamoto, T., Tatsuta, M., Toyota, Y., Fujita, K., Kato, K., Maeda, E., Nomura, T., Miyoshi, H., Yoneyama, H., Himoto, T., Fujiwara, S., Kobara, H., Mori, H., Niki, T., Ono, M., Hirashima, M., and Masaki, T. (2015) MicroRNA profiles following metformin treatment in a mouse model of nonalcoholic steatohepatitis. Int. J. Mol. Med. 35, 877-884
74. Sung-E, C., Ting, F., Sunmi, S., Dong-Hyun, K., Eunkyung, Y., Kwan-Woo, L., Yup, K., Xiaoling, L., Byron, K., and Jongsook Kim, K. (2008) Elevated microRNA-34a in obesity reduces NAD+ levels and SIRT1 activity by directly targeting NAMPT. Aging Cell 28, 4439-4448
75. Yamakuchi, M., Ferlito, M., and Lowenstein, C. J. (2008) miR-34a repression of SIRT1 regulates apoptosis. Proc. Natl. Acad. Sci. USA 105, 13421-13426
76. Do, M.T., Kim, H.G., Choi, J.H., and Jeong, H.G. (2014) Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents. Free Radic. Biol. Med. 74, 21-34
77. Cifarelli, V., Lashinger, L.M., Devlin, K. L., Dunlap, S.M., Huang, J., Kaaks, R., Pollak, M. N., and Hursting, S. D. (2015) Metformin and rapamycin reduce pancreatic cancer growth in obese prediabetic mice by distinct microRNA-regulated mechanisms. Diabetes 64, 1632-1642
78. Lai, M., Du, G., Shi, R., Yao, J., Yang, G., Wei, Y., Zhang, D., Xu, Z., Zhang, R., Li, Y., Li, Z., and Wang, L. (2015) MiR-34a inhibits migration and invasion by regulating the SIRT1/p53 pathway in human SW480 cells. Mol. Med. Rep. 11, 3301-3307
79. Arunachalam, G., Lakshmanan, A. P., Samuel, S.M., Triggle, C., and Ding, H. (2015) Molecular interplay between microRNA-34a and sirtuin1 in hyperglycaemia-mediated impaired angiogenesis in endothelial cells: effects of metformin. J. Pharmacol. Exp. Ther. 356, 314-323
80. Yu, X., Zhang, L., Wen, G., Zhao, H., Luong, L. A., Chen, Q., Huang, Y., Zhu, J., Ye, S., Xu, Q., Wang, W., and Xiao, Q. (2015) Upregulated sirtuin 1 by miRNA-34a is required for smooth muscle cell differentiation frompluripotent stemcells. Cell Death Differ. 22, 1170-1180
81. Xu, J.-Q., Liu, P., Si, M.-J., and Ding, X.-Y. (2013) MicroRNA-126 inhibits osteosarcoma cells proliferation by targeting Sirt1. Tumour Biol. 34, 3871-3877
82. Zhang, L., Huang, D., Wang, Q., Shen, D., Wang, Y., Chen, B., Zhang, J., and Gai, L. (2014) MiR-132 inhibits expression of SIRT1 and induces pro-inflammatory processes of vascular endothelial inflammation through blockade of the SREBP-1c metabolic pathway. Cardiovasc. Drugs Ther. 28, 303-311
83. Strum, J. C., Johnson, J. H., Ward, J., Xie, H., Feild, J., Hester, A., Alford, A., and Waters, K. M. (2009) MicroRNA 132 regulates nutritional stress-induced chemokine production through repression of SirT1. Mol. Endocrinol. 23, 1876-1884
84. Xu, J., Li, L., Yun, H. F., and Han, Y. S. (2015) MiR-138 promotes smooth muscle cells proliferation and migration in db/db mice through down-regulation of SIRT1. Biochem. Biophys. Res. Commun. 463, 1159-1164
85. Ahn, J., Lee, H., Jung, C. H., Jeon, T. I., and Ha, T. Y. (2013) MicroRNA-146b promotes adipogenesis by suppressing the SIRT1-FOXO1 cascade. EMBO Mol. Med. 5, 1602-1612
86. Zhou, B., Li, C., Qi, W., Zhang, Y., Zhang, F., Wu, J. X., Hu, Y. N., Wu, D.M., Liu, Y., Yan, T.T., Jing, Q., Liu, M. F., and Zhai, Q. W. (2012) Downregulation of miR-181a upregulates sirtuin-1 (SIRT1) and improves hepatic insulin sensitivity. Diabetologia 55, 2032-2043
87. Mortuza, R., Feng, B., and Chakrabarti, S. (2014) miR-195 regulates SIRT1-mediated changes in diabetic retinopathy. Diabetologia 57, 1037-1046
88. Zhang, S., Liu, L., Wang, R., Tuo, H., Guo, Y., Yi, L., Wang, J., and Wang, D. (2013) MiR-199a-5p promotes migration and tube formation of human cytomegalovirus-infected endothelial cells through downregulation of SIRT1 and eNOS. Arch. Virol. 158, 2443-2452
89. Rane, S., He, M., Sayed, D., Vashistha, H., Malhotra, A., Sadoshima, J., Vatner, D. E., Vatner, S. F., and Abdellatif, M. (2009) Downregulation of miR-199a derepresses hypoxiainducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ. Res. 104, 879-886
90. Shi, Y., Huang, J., Zhou, J., Liu, Y., Fu, X., Li, Y., Yin, G., and Wen, J. (2015) MicroRNA-204 inhibits proliferation, migration, invasion and epithelial-mesenchymal transition in osteosarcoma cells via targeting Sirtuin 1. Oncol. Rep. 34, 399-406
91. Zhang, L., Wang, X., and Chen, P. (2013) MiR-204 down regulates SIRT1 and reverts SIRT1-induced epithelial-mesenchymal transition, anoikis resistance and invasion in gastric cancer cells. BMC Cancer 13, 290
92. Ramalinga, M., Roy, A., Srivastava, A., Bhattarai, A., Harish, V., Suy, S., Collins, S., and Kumar, D. (2015) MicroRNA-212 negatively regulates starvation induced autophagy in prostate cancer cells by inhibiting SIRT1 and is a modulator of angiogenesis and cellular senescence. Oncotarget 6, 34446-34457
93. Menghini, R., Casagrande, V., Cardellini, M., Martelli, E., Terrinoni, A., Amati, F., Vasa-Nicotera, M., Ippoliti, A., Novelli, G., Melino, G., Lauro, R., and Federici, M. (2009) MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation 120, 1524-1532
94. Liu, P., and Wilson, M. J. (2012) miR-520c and miR-373 upregulate MMP9 expression by targeting mTOR and SIRT1, and activate the Ras/Raf/MEK/Erk signaling pathway and NF-κB factor in human fibrosarcoma cells. J. Cell. Physiol. 227, 867-876
95. Zhang, H., Feng, Z., Huang, R., Xia, Z., Xiang, G., and Zhang, J. (2014) MicroRNA-449 suppresses proliferation of hepatoma cell lines through blockade lipid metabolic pathway related to SIRT1. Int. J. Oncol. 45, 2143-2152
96. Bou Kheir, T., Futoma-Kazmierczak, E., Jacobsen, A., Krogh, A., Bardram, L., Hother, C., Grønbæk, K., Federspiel, B., Lund, A. H., and Friis-Hansen, L. (2011) miR-449 inhibits cell proliferation and is down-regulated in gastric cancer. Mol. Cancer 10, 29
97. Liu, Y., Li, X., Zhu, S., Zhang, J. G., Yang, M., Qin, Q., Deng, S. C., Wang, B., Tian, K., Liu, L., Niu, Y., Wang, C. Y., and Zhao, G. (2015) Ectopic expression of miR-494 inhibited the proliferation, invasion and chemoresistance of pancreatic cancer by regulating SIRT1 and c-Myc. Gene Ther. 22, 729-738
98. Li, J., Dong, G., Wang, B., Gao, W., and Yang, Q. (2015) miR-543 promotes gastric cancer cell proliferation by targeting SIRT1. Biochem. Biophys. Res. Commun. 469, 15-21
99. Raver-Shapira, N., Marciano, E., Meiri, E., Spector, Y., Rosenfeld, N., Moskovits, N., Bentwich, Z., and Oren, M. (2007) Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol. Cell 26, 731-743
100. Lou, G., Liu, Y., Wu, S., Xue, J., Yang, F., Fu, H., Zheng, M., and Chen, Z. (2015) The p53/miR-34a/SIRT1 positive feedback loop in quercetin-induced apoptosis. Cell. Physiol. Biochem. 35, 2192-2202
101. Xu, M., Lu, L., Mao, B., Lü, X., Wu, X., Li, L., and Liu, D. (2012) Mutual inhibition between miR-34a and SIRT1 contributes to regulation of DNA double-strand break repair. Chin. Sci. Bull. 58, 979-985
102. Bullock, A. N., and Fersht, A. R. (2001) Rescuing the function of mutant p53. Nat. Rev. Cancer 1, 68-76
103. Buler, M., Aatsinki, S.-M., Izzi, V., Uusimaa, J., and Hakkola, J. (2014) SIRT5 is under the control of PGC-1α and AMPK and is involved in regulation of mitochondrial energy metabolism. FASEB J. 28, 3225-3237
104. Xu, Y., Zalzala, M., Xu, J., Li, Y., Yin, L., and Zhang, Y. (2015) A metabolic stress-inducible miR-34a-HNF4α pathway regulates lipid and lipoprotein metabolism. Nat. Commun. 6, 7466
105. Zhang, S., Chen, P., Huang, Z., Hu, X., Chen, M., Hu, S., Hu, Y., and Cai, T. (2015) Sirt7 promotes gastric cancer growth and inhibits apoptosis by epigenetically inhibiting miR-34a. Sci. Rep. 5, 9787
106. Lefort, K., Brooks, Y., Ostano, P., Cario-André, M., Calpini, V., Guinea-Viniegra, J., Albinger-Hegyi, A., Hoetzenecker, W., Kolfschoten, I., Wagner, E. F., Werner, S., and Dotto, G. P. (2013) A miR-34a-SIRT6 axis in the squamous cell differentiation network. EMBO J. 32, 2248-2263
107. Flick, F., and Lüscher, B. (2012) Regulation of sirtuin function by posttranslational modifications. Front. Pharmacol. 3, 29
108. Revollo, J. R., and Li, X. (2013) The ways and means that fine tune Sirt1 activity. Trends Biochem. Sci. 38, 160-167
109. Sasaki, T., Maier, B., Koclega, K. D., Chruszcz, M., Gluba, W., Stukenberg, P. T., Minor, W., and Scrable, H. (2008) Phosphorylation regulates SIRT1 function. PLoS One 3, e4020
110. Nasrin, N., Kaushik, V. K., Fortier, E., Wall, D., Pearson, K. J., de Cabo, R., and Bordone, L. (2009) JNK1 phosphorylates SIRT1 and promotes its enzymatic activity. PLoS One 4, e8414
111. Ford, J., Ahmed, S., Allison, S., Jiang, M., and Milner, J. (2008) JNK2-dependent regulation of SIRT1 protein stability. Cell Cycle 7, 3091-3097
112. Peng, L., Yuan, Z., Li, Y., Ling, H., Izumi, V., Fang, B., Fukasawa, K., Koomen, J., Chen, J., and Seto, E. (2015) Ubiquitinated sirtuin 1 (SIRT1) function is modulated during DNA damage-induced cell death and survival. J. Biol. Chem. 290, 8904-8912
113. Yang, Y., Fu, W., Chen, J., Olashaw, N., Zhang, X., Nicosia, S. V., Bhalla, K., and Bai, W. (2007) SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stress. Nat. Cell Biol. 9, 1253-1262
114. Caito, S., Rajendrasozhan, S., Cook, S., Chung, S., Yao, H., Friedman, A.E., Brookes, P. S., and Rahman, I. (2010) SIRT1 is a redox-sensitive deacetylase that is post-translationally modified by oxidants and carbonyl stress. FASEB J. 24, 3145-3159
115. Liu, X., Wang, D., Zhao, Y., Tu, B., Zheng, Z., Wang, L., Wang, H., Gu, W., Roeder, R. G., and Zhu, W.-G. (2011) Methyltransferase Set7/9 regulates p53 activity by interacting with Sirtuin 1 (SIRT1). Proc. Natl. Acad. Sci. USA 108, 1925-1930
116. Lin, Z., Yang, H., Kong, Q., Li, J., Lee, S. M., Gao, B., Dong, H., Wei, J., Song, J., Zhang, D. D., and Fang, D. (2012) USP22 antagonizes p53 transcriptional activation by deubiquitinating Sirt1 to suppress cell apoptosis and is required for mouse embryonic development. Mol. Cell 46, 484-494
117. Vaquero, A., Scher, M., Lee, D., Erdjument-Bromage, H., Tempst, P., and Reinberg, D. (2004) Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin. Mol. Cell 16, 93-105
118. Guo, X., Williams, J.G., Schug, T. T., and Li, X. (2010) DYRK1A and DYRK3 promote cell survival through phosphorylation and activation of SIRT1. J. Biol. Chem. 285, 13223-13232
119. Kanfi, Y., Peshti, V., Gozlan, Y.M., Rathaus, M., Gil, R., and Cohen, H. Y. (2008) Regulation of SIRT1 protein levels by nutrient availability. FEBS Lett. 582, 2417-2423
120. Frye, R. A. (1999) Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochem. Biophys. Res. Commun. 260, 273-279
121. North, B. J., Marshall, B. L., Borra, M. T., Denu, J.M., and Verdin, E. (2003) The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol. Cell 11, 437-444
122. Teng, Y.-B., Jing, H., Aramsangtienchai, P., He, B., Khan, S., Hu, J., Lin, H., and Hao, Q. (2015) Efficient demyristoylase activity of SIRT2 revealed by kinetic and structural studies. Sci. Rep. 5, 8529
123. Wang, F., Nguyen, M., Qin, F. X. F., and Tong, Q. (2007) SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction. Aging Cell 6, 505-514
124. Li, W., Zhang, B., Tang, J., Cao, Q., Wu, Y., Wu, C., Guo, J., Ling, E.-A., and Liang, F. (2007) Sirtuin 2, amammalian homolog of yeast silent information regulator-2 longevity regulator, is an oligodendroglial protein that decelerates cell differentiation through deacetylating alpha-tubulin. J. Neurosci. 27, 2606-2616
125. Maxwell, M. M., Tomkinson, E. M., Nobles, J., Wizeman, J. W., Amore, A. M., Quinti, L., Chopra, V., Hersch, S. M., and Kazantsev, A. G. (2011) The sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS. Hum. Mol. Genet. 20, 3986-3996
126. Gomes, P., Outeiro, T. F., and Cavadas, C. (2015) Emerging role of sirtuin 2 in the regulation of mammalian metabolism. Trends Pharmacol. Sci. 36, 756-768
127. Park, J.-M., Kim, T.-H., Jo, S.-H., Kim, M.-Y., and Ahn, Y.-H. (2015) Acetylation of glucokinase regulatory protein decreases glucose metabolism by suppressing glucokinase activity. Sci. Rep. 5, 17395
128. Jiang, W., Wang, S., Xiao, M., Lin, Y., Zhou, L., Lei, Q., Xiong, Y., Guan, K.-L., and Zhao, S. (2011) Acetylation regulates gluconeogenesis by promoting PEPCK1 degradation via recruiting the UBR5 ubiquitin ligase. Mol. Cell 43, 33-44
129. Krishnan, J., Danzer, C., Simka, T., Ukropec, J., Walter, K.M., Kumpf, S., Mirtschink, P., Ukropcova, B., Gasperikova, D., Pedrazzini, T., and Krek, W. (2012) Dietary obesity-associated Hif1α activation in adipocytes restricts fatty acid oxidation and energy expenditure via suppression of the Sirt2-NAD+ system. Genes Dev. 26, 259-270
130. Wang, F., and Tong, Q. (2009) SIRT2 suppresses adipocyte differentiation by deacetylating FOXO1 and enhancing FOXO1's repressive interaction with PPARgamma. Mol. Biol. Cell 20, 801-808
131. Zhong, L., D'Urso, A., Toiber, D., Sebastian, C., Henry, R. E., Vadysirisack, D.D., Guimaraes, A., Marinelli, B., Wikstrom, J.D., Nir, T., Clish, C. B., Vaitheesvaran, B., Iliopoulos, O., Kurland, I., Dor, Y., Weissleder, R., Shirihai, O. S., Ellisen, L. W., Espinosa, J. M., and Mostoslavsky, R. (2010) The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell 140, 280-293
132. Feldman, J. L., Baeza, J., and Denu, J. M. (2013) Activation of the protein deacetylase SIRT6 by long-chain fatty acids and widespread deacylation by mammalian sirtuins. J. Biol. Chem. 288, 31350-31356
133. Jin, Y.H., Kim, Y. J., Kim, D.W., Baek, K.H., Kang, B. Y., Yeo, C. Y., and Lee, K. Y. (2008) Sirt2 interacts with 14-3-3 beta/gamma and downregulates the activity of p53. Biochem. Biophys. Res. Commun. 368, 690-695
134. Choi, Y. H., Kim, H., Lee, S. H., Jin, Y.-H., and Lee, K. Y. (2014) Src regulates the activity of SIRT2. Biochem. Biophys. Res. Commun. 450, 1120-1125
135. Han, Y., Jin, Y. H., Kim, Y. J., Kang, B. Y., Choi, H. J., Kim, D. W., Yeo, C. Y., and Lee, K. Y. (2008) Acetylation of Sirt2 by p300 attenuates its deacetylase activity. Biochem. Biophys. Res. Commun. 375, 576-580
136. Choi, Y.H., Kim, H., Han, Y., Jin, Y.-H., and Lee, K.Y. (2014) Cbl regulates the activity of SIRT2. Biochem. Biophys. Res. Commun. 453, 557-562
137. Dan, L., Klimenkova, O., Klimiankou, M., Klusman, J. H., van den Heuvel-Eibrink, M. M., Reinhardt, D., Welte, K., and Skokowa, J. (2012) The role of sirtuin 2 activation by nicotinamide phosphoribosyl transferase in the aberrant proliferation and survival of myeloid leukemia cells. Haematologica 97, 551-559
138. Kim, H.-S., Vassilopoulos, A., Wang, R.-H., Lahusen, T., Xiao, Z., Xu, X., Li, C., Veenstra, T.D., Li, B., Yu, H., Ji, J., Wang, X.W., Park, S.-H., Cha, Y. I., Gius, D., and Deng, C.-X. (2011) SIRT2maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity. Cancer Cell 20, 487-499
139. Hiratsuka, M., Inoue, T., Toda, T., Kimura, N., Shirayoshi, Y., Kamitani, H., Watanabe, T., Ohama, E., Tahimic, C.G.T., Kurimasa, A., and Oshimura, M. (2003) Proteomics-based identification of differentially expressedgenes inhumangliomas: down-regulation of SIRT2 gene. Biochem. Biophys. Res. Commun. 309, 558-566
140. Pandithage, R., Lilischkis, R., Harting, K., Wolf, A., Jedamzik, B., Lüscher-Firzlaff, J., Vervoorts, J., Lasonder, E., Kremmer, E., Knöll, B., and Lüscher, B. (2008) The regulation of SIRT2 function by cyclin-dependent kinases affects cellmotility. J. Cell Biol. 180, 915-929
141. Al-Bassam, J., and Corbett, K. D. (2012) α-Tubulin acetylation from the inside out. Proc. Natl. Acad. Sci. USA 109, 19515-19516
142. Eskandarian, H. a., Impens, F., Nahori, M. -a., Soubigou, G., Coppee, J.-Y., Cossart, P., and Hamon, M. a. (2013) A role for SIRT2-dependent histone H3K18 deacetylation in bacterial infection. Science 341, 1238858
143. Hochegger, H., Takeda, S., and Hunt, T. (2008) Cyclin-dependent kinases and cell-cycle transitions: does one fit all? Nat. Rev. Mol. Cell Biol. 9, 910-916
144. North, B. J., and Verdin, E. (2007) Mitotic regulation of SIRT2 by cyclin-dependent kinase 1-dependent phosphorylation. J. Biol. Chem. 282, 19546-19555
145. Choi, Y. H., Kim, H., Lee, S. H., Jin, Y. H., and Lee, K. Y. (2013) ERK1/2 regulates SIRT2 deacetylase activity. Biochem. Biophys. Res. Commun. 437, 245-249
146. Ji, S., Doucette, J. R., and Nazarali, A. J. (2011) Sirt2 is a novel in vivo downstream target of Nkx2.2 and enhances oligodendroglial cell differentiation. J. Mol. Cell Biol. 3, 351-359
147. Valle, C., Salvatori, I., Gerbino, V., Rossi, S., Palamiuc, L., René, F., and Carrì, M. T. (2014) Tissue-specific deregulation of selected HDACs characterizes ALS progression in mouse models: pharmacological characterization of SIRT1 and SIRT2 pathways. Cell Death Dis. 5, e1296
148. Wang, J.-Y., Li, H., Ma, C.-M., Wang, J.-L., Lai, X.-S., and Zhou, S.-F. (2015) Acupuncture may exert its therapeutic effect through microRNA-339/Sirt2/NFκB/FOXO1 axis. BioMed Res. Int. 2015, 428591
149. Hirschey, M. D., Shimazu, T., Jing, E., Grueter, C. A., Collins, A. M., Aouizerat, B., Stančáková, A., Goetzman, E., Lam, M.M., Schwer, B., Stevens, R. D., Muehlbauer, M. J., Kakar, S., Bass, N. M., Kuusisto, J., Laakso, M., Alt, F. W., Newgard, C. B., Farese, R. V., Jr., Kahn, C. R., and Verdin, E. (2011) SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol. Cell 44, 177-190
150. Rardin, M. J., Newman, J. C., Held, J. M., Cusack, M. P., Sorensen, D. J., Li, B., Schilling, B., Mooney, S. D., Kahn, C. R., Verdin, E., and Gibson, B.W. (2013) Label-free quantitative proteomics of the lysine acetylome in mitochondria identifies substrates of SIRT3 in metabolic pathways. Proc. Natl. Acad. Sci. USA 110, 6601-6606
151. Palacios, O. M., Carmona, J. J., Michan, S., Chen, K. Y., Manabe, Y., Ward III, J.L., Goodyear, L. J., and Tong, Q. (2009) Diet andexercise signals regulate SIRT3 and activate AMPK and PGC-1alpha in skeletal muscle. Aging (Albany, N.Y.) 1, 771-783
152. Hirschey, M. D., Shimazu, T., Goetzman, E., Jing, E., Schwer, B., Lombard, D. B., Grueter, C. A., Harris, C., Biddinger, S., Ilkayeva, O.R., Stevens, R. D., Li, Y., Saha, A.K., Ruderman, N.B., Bain, J. R., Newgard, C. B., Farese, R. V., Jr., Alt, F. W., Kahn, C. R., and Verdin, E. (2010) SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464, 121-125
153. Kendrick, A. A., Choudhury, M., Rahman, S. M., McCurdy, C. E., Friederich, M., VanHove, J. L.K., Watson, P.A., Birdsey, N., Bao, J., Gius, D., Sack, M. N., Jing, E., Kahn, C. R., Friedman, J. E., and Jonscher, K. R. (2011) Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation. Biochem. J. 433, 505-514
154. Yechoor, V. K., Patti, M.-E., Ueki, K., Laustsen, P. G., Saccone, R., Rauniyar, R., and Kahn, C. R. (2004) Distinct pathways of insulinregulated versus diabetes-regulated gene expression: an in vivo analysis in MIRKOmice. Proc. Natl. Acad. Sci. USA 101, 16525-16530
155. Mortuza, R., Chen, S., Feng, B., Sen, S., and Chakrabarti, S. (2013) High glucose induced alteration of SIRTs in endothelial cells causes rapid aging in a p300 and FOXO regulated pathway. PLoS One 8, e54514
156. Kong, X., Wang, R., Xue, Y., Liu, X., Zhang, H., Chen, Y., Fang, F., and Chang, Y. (2010) Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis. PLoS One 5, e11707
157. Giralt, A., Hondares, E., Villena, J.A., Ribas, F., Díaz-Delfín, J., Giralt, M., Iglesias, R., and Villarroya, F. (2011) Peroxisome proliferatoractivated receptor-gamma coactivator-1alpha controls transcription of the Sirt3 gene, an essential component of the thermogenic brown adipocyte phenotype. J. Biol. Chem. 286, 16958-16966
158. Satterstrom, F. K., Swindell, W. R., Laurent, G., Vyas, S., Bulyk, M. L., and Haigis, M. C. (2015) Nuclear respiratory factor 2 induces SIRT3 expression. Aging Cell 14, 818-825
159. Mootha, V. K., Handschin, C., Arlow, D., Xie, X., St Pierre, J., Sihag, S., Yang, W., Altshuler, D., Puigserver, P., Patterson, N., Willy, P. J., Schulman, I.G., Heyman, R. A., Lander, E. S., and Spiegelman, B.M. (2004) Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle [published correction in Proc. Natl. Acad. Sci. USA (2005), 102, 10405]. Proc. Natl. Acad. Sci. USA 101, 6570-6575
160. Vercauteren, K., Gleyzer, N., and Scarpulla, R. C. (2008) PGC-1-related coactivator complexes with HCF-1 and NRF-2beta in mediating NRF-2(GABP)-dependent respiratory gene expression. J. Biol. Chem. 283, 12102-12111
161. Wang, Z., Zhang, L., Liang, Y., Zhang, C., Xu, Z., Zhang, L., Fuji, R., Mu, W., Li, L., Jiang, J., Ju, Y., and Wang, Z. (2015) Cyclic AMP Mimics the anti-ageing effects of calorie restriction by up-regulating sirtuin. Sci. Rep. 5, 12012
162. Buler, M., Aatsinki, S.-M., Izzi, V., and Hakkola, J. (2012) Metformin reduces hepatic expression of SIRT3, themitochondrial deacetylase controlling energy metabolism. PLoS One 7, e49863
163. Shi, L., Zhang, T., Zhou, Y., Zeng, X., Ran, L., Zhang, Q., Zhu, J., and Mi, M. (2015) Dihydromyricetin improves skeletal muscle insulin sensitivity by inducing autophagy via the AMPK-PGC-1α-Sirt3 signaling pathway. Endocrine 50, 378-389
164. Chen, Y., Qing, W., Sun, M., Lv, L., Guo, D., and Jiang, Y. (2015) Melatonin protects hepatocytes against bile acid-induced mitochondrial oxidative stress via the AMPK-SIRT3-SOD2 pathway. Free Radic. Res. 49, 1275-1284
165. Yu, X., Zhang, L., Yang, X., Huang, H., Huang, Z., Shi, L., Zhang, H., and Du, G. (2012) Salvianolic acid A protects the peripheral nerve function in diabetic rats through regulation of the AMPK-PGC1α-Sirt3 axis. Molecules 17, 11216-11228
166. Brandauer, J., Andersen, M. A., Kellezi, H., Risis, S., Frøsig, C., Vienberg, S. G., and Treebak, J. T. (2015) AMP-activated protein kinase controls exercise training- and AICAR-induced increases in SIRT3 and MnSOD. Front. Physiol. 6, 85
167. Song, Y., Shi, J., Wu, Y., Han, C., Zou, J., Shi, Y., and Liu, Z. (2014) Metformin ameliorates insulin resistance in L6 rat skeletal muscle cells through upregulation of SIRT3. Chin. Med. J. (Engl.) 127, 1523-1529
168. Yang, W., Zou, Y., Zhang, M., Zhao, N., Tian, Q., Gu, M., Liu, W., Shi, R., Lü, Y., and Yu, W. (2015) Mitochondrial Sirt3 expression is decreased in APP/PS1 double transgenic mouse model of Alzheimer's disease. Neurochem. Res. 40, 1576-1582
169. Weir, H. J. M., Murray, T. K., Kehoe, P. G., Love, S., Verdin, E.M., O'Neill, M. J., Lane, J. D., and Balthasar, N. (2012) CNS SIRT3 expression is altered by reactive oxygen species and in Alzheimer's disease. PLoS One 7, e48225
170. Ahuja, N., Schwer, B., Carobbio, S., Waltregny, D., North, B. J., Castronovo, V., Maechler, P., and Verdin, E. (2007) Regulation of insulin secretion by SIRT4, amitochondrial ADP-ribosyltransferase. J. Biol. Chem. 282, 33583-33592
171. Haigis, M.C., Mostoslavsky, R., Haigis, K.M., Fahie, K., Christodoulou, D. C., Murphy, A. J., Valenzuela, D. M., Yancopoulos, G. D., Karow, M., Blander, G., Wolberger, C., Prolla, T.A., Weindruch, R., Alt, F.W., and Guarente, L. (2006) SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic β cells. Cell 126, 941-954
172. Du, J., Jiang, H., and Lin, H. (2009) Investigating the ADP-ribosyltransferase activity of sirtuins with NAD analogues and 32PNAD. Biochemistry 48, 2878-2890
173. Nasrin, N., Wu, X., Fortier, E., Feng, Y., Bare', O.C., Chen, S., Ren, X., Wu, Z., Streeper, R. S., and Bordone, L. (2010) SIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells. J. Biol. Chem. 285, 31995-32002
174. Laurent, G., German, N. J., Saha, A. K., de Boer, V. C. J., Davies, M., Koves, T. R., Dephoure, N., Fischer, F., Boanca, G., Vaitheesvaran, B., Lovitch, S. B., Sharpe, A.H., Kurland, I. J., Steegborn, C., Gygi, S. P., Muoio, D. M., Ruderman, N. B., and Haigis, M. C. (2013) SIRT4 coordinates the balance between lipid synthesis and catabolism by repressing malonyl CoA decarboxylase. Mol. Cell 50, 686-698
175. Laurent, G., de Boer, V. C. J., Finley, L. W. S., Sweeney, M., Lu, H., Schug, T. T., Cen, Y., Jeong, S. M., Li, X., Sauve, A. A., and Haigis, M. C. (2013) SIRT4 represses peroxisome proliferator-activated receptorα activity to suppresshepatic fat oxidation. Mol. Cell. Biol. 33, 4552-4561
176. Mathias, R. A., Greco, T. M., Oberstein, A., Budayeva, H. G., Chakrabarti, R., Rowland, E.A., Kang, Y., Shenk, T., and Cristea, I.M. (2014) Sirtuin 4 is a lipoamidase regulating pyruvate dehydrogenase complex activity. Cell 159, 1615-1625
177. Fan, J., Shan, C., Kang, H.-B., Elf, S., Xie, J., Tucker, M., Gu, T.-L., Aguiar, M., Lonning, S., Chen, H., Mohammadi, M., Britton, L.-M. P., Garcia, B. A., Alečković, M., Kang, Y., Kaluz, S., Devi, N., Van Meir, E. G., Hitosugi, T., Seo, J. H., Lonial, S., Gaddh, M., Arellano, M., Khoury, H. J., Khuri, F. R., Boggon, T. J., Kang, S., and Chen, J. (2014) Tyr phosphorylation of PDP1 toggles recruitment between ACAT1 and SIRT3 to regulate the pyruvate dehydrogenase complex. Mol. Cell 53, 534-548
178. Do Amaral, M. E. C., Ueno, M., Oliveira, C. A.M., Borsonello, N. C., Vanzela, E. C., Ribeiro, R. A., Alves, P. L., Barbosa, H. C., Carneiro, E. M., and Boschero, A. C. (2011) Reduced expression of SIRT1 is associated with diminished glucose-induced insulin secretion in islets from calorie-restricted rats. J. Nutr. Biochem. 22, 554-559
179. Chen, Y.-R., Fang, S.-R., Fu, Y.-C., Zhou, X.-H., Xu, M.-Y., and Xu, W.-C. (2010) Calorie restrictiononinsulin resistance and expression of SIRT1 and SIRT4 in rats. Biochem. Cell Biol. 88, 715-722
180. Csibi, A., Fendt, S.-M., Li, C., Poulogiannis, G., Choo, A. Y., Chapski, D. J., Jeong, S. M., Dempsey, J. M., Parkhitko, A., Morrison, T., Henske, E.P., Haigis, M.C., Cantley, L.C., Stephanopoulos, G., Yu, J., and Blenis, J. (2013) The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4. Cell 153, 840-854
181. Jin, L., Alesi, G.N., and Kang, S. (2016) Glutaminolysis as a target for cancer therapy. Oncogene. 35, 3619-3625
182. Wang, L., Zhou, H., Wang, Y., Cui, G., and Di, L.-J. (2015) CtBP maintains cancer cell growth and metabolic homeostasis via regulating SIRT4. Cell Death Dis. 6, e1620
183. Huang, G., Cheng, J., Yu, F., Liu, X., Yuan, C., Liu, C., Chen, X., and Peng, Z. (2016) Clinical and therapeutic significance of sirtuin-4 expression in colorectal cancer. Oncol. Rep. 35, 2801-2810
184. Huang, G., Cui, F., Yu, F., Lu, H., Zhang, M., Tang, H., and Peng, Z. (2015) Sirtuin-4 (SIRT4) is downregulated and associated with some clinicopathological features in gastric adenocarcinoma. Biomed. Pharmacother. 72, 135-139
185. Mahjabeen, I., and Kayani, M. A. (2016) Loss of mitochondrial tumor suppressor genes expression is associated with unfavorable clinical outcome in head and neck squamous cell carcinoma: data from retrospective study. PLoS One 11, e0146948
186. Jeong, S. M., Xiao, C., Finley, L. W. S., Lahusen, T., Souza, A. L., Pierce, K., Li, Y.-H., Wang, X., Laurent, G., German, N. J., Xu, X., Li, C., Wang, R.-H., Lee, J., Csibi, A., Cerione, R., Blenis, J., Clish, C. B., Kimmelman, A., Deng, C.-X., and Haigis, M. C. (2013) SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism. Cancer Cell 23, 450-463
187. Miyo, M., Yamamoto, H., Konno, M., Colvin, H., Nishida, N., Koseki, J., Kawamoto, K., Ogawa, H., Hamabe, A., Uemura, M., Nishimura, J., Hata, T., Takemasa, I., Mizushima, T., Doki, Y., Mori, M., and Ishii, H. (2015) Tumour-suppressive function of SIRT4 in human colorectal cancer. Br. J. Cancer 113, 492-499
188. Jeong, S.M., Lee, A., Lee, J., and Haigis, M. C. (2014) SIRT4 protein suppresses tumor formationin genetic models of Myc-induced Bcell lymphoma. J. Biol. Chem. 289, 4135-4144
189. Lang, A., Grether-Beck, S., Singh, M., Kuck, F., Jakob, S., Kefalas, A., Altinoluk-Hambüchen, S., Graffmann, N., Schneider, M., Lindecke, A., Brenden, H., Felsner, I., Ezzahoini, H., Marini, A., Weinhold, S., Vierkötter, A., Tigges, J., Schmidt, S., Stühler, K., Köhrer, K., Uhrberg, M., Haendeler, J., Krutmann, J., and Piekorz, R. P. (2016) MicroRNA-15b regulates mitochondrial ROS production and the senescence-associated secretory phenotype through sirtuin 4/SIRT4. Aging (Albany, N.Y.) 8, 484-509
190. Komlos, D., Mann, K. D., Zhuo, Y., Ricupero, C. L., Hart, R. P., Liu, A. Y.-C., and Firestein, B. L. (2013) Glutamate dehydrogenase 1 and SIRT4 regulate glial development. Glia 61, 394-408
191. Wong, D. W., Soga, T., and Parhar, I. S. (2015) Aging and chronic administration of serotonin-selective reuptake inhibitor citalopram upregulate Sirt4 gene expression in the preoptic area of malemice. Front. Genet. 6, 281
192. Michaelis, E. K., Wang, X., Pal, R., Bao, X., Hascup, K. N., Wang, Y., Wang, W.-T., Hui, D., Agbas, A., Choi, I.-Y., Belousov, A., and Gerhardt, G.A. (2011) Neuronal Glud1 (glutamatedehydrogenase 1) over-expressing mice: increased glutamate formation and synaptic release, loss of synaptic activity, and adaptive changes in genomic expression. Neurochem. Int. 59, 473-481
193. Acs, Z., Bori, Z., Takeda, M., Osvath, P., Berkes, I., Taylor, A.W., Yang, H., and Radak, Z. (2014) High altitude exposure alters gene expression levels of DNA repair enzymes, and modulates fatty acid metabolism by SIRT4 induction in human skeletal muscle. Respir. Physiol. Neurobiol. 196, 33-37
194. Boylston, J.A., Sun, J., Chen, Y., Gucek, M., Sack, M.N., and Murphy, E. (2015) Characterization of the cardiac succinylome and its role in ischemia-reperfusion injury. J. Mol. Cell. Cardiol. 88, 73-81
195. Nishida, Y., Rardin, M. J., Carrico, C., He, W., Sahu, A. K., Gut, P., Najjar, R., Fitch, M., Hellerstein, M., Gibson, B.W., and Verdin, E. (2015) SIRT5 regulates both cytosolic and mitochondrial protein malonylation with glycolysis as a major target. Mol. Cell 59, 321-332
196. Rodgers, J.T., Lerin, C., Gerhart-Hines, Z., and Puigserver, P. (2008) Metabolic adaptations through the PGC-1α and SIRT1 pathways. FEBS Lett. 582, 46-53
197. Ogura, M., Nakamura, Y., Tanaka, D., Zhuang, X., Fujita, Y., Obara, A., Hamasaki, A., Hosokawa, M., and Inagaki, N. (2010) Overexpression of SIRT5 confirms its involvement in deacetylation and activation of carbamoylphosphate synthetase 1. Biochem. Biophys. Res. Commun. 393, 73-78
198. Nakagawa, T., Lomb, D. J., Haigis, M. C., and Guarente, L. (2009) SIRT5Deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 137, 560-570
199. Schwer, B., Eckersdorff, M., Li, Y., Silva, J. C., Fermin, D., Kurtev, M. V., Giallourakis, C., Comb, M. J., Alt, F. W., and Lombard, D. B. (2009) Calorie restriction alters mitochondrial protein acetylation. Aging Cell 8, 604-606
200. Lage, R., Diéguez, C., Vidal-Puig, A., and López, M. (2008) AMPK: a metabolic gauge regulating whole-body energy homeostasis. Trends Mol. Med. 14, 539-549
201. Lieber, C. S., Leo, M.A., Wang, X., and Decarli, L.M. (2008) Alcohol alters hepatic FoxO1, p53, and mitochondrial SIRT5 deacetylation function. Biochem. Biophys. Res. Commun. 373, 246-252
202. Lu, W., Zuo, Y., Feng, Y., and Zhang, M. (2014) SIRT5 facilitates cancer cell growth and drug resistance in non-small cell lung cancer. Tumour Biol. 35, 10699-10705
203. Lin, Z.-F., Xu, H.-B., Wang, J.-Y., Lin, Q., Ruan, Z., Liu, F.-B., Jin, W., Huang, H.-H., and Chen, X. (2013) SIRT5 desuccinylates and activates SOD1 to eliminate ROS. Biochem. Biophys. Res. Commun. 441, 191-195
204. Liszt, G., Ford, E., Kurtev, M., and Guarente, L. (2005) Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase. J. Biol. Chem. 280, 21313-21320
205. Kanfi, Y., Naiman, S., Amir, G., Peshti, V., Zinman, G., Nahum, L., Bar-Joseph, Z., and Cohen, H. Y. (2012) The sirtuin SIRT6 regulates lifespan in male mice. Nature 483, 218-221
206. Michishita, E., McCord, R. A., Berber, E., Kioi, M., Padilla-Nash, H., Damian, M., Cheung, P., Kusumoto, R., Kawahara, T. L. A., Barrett, J.C., Chang, H. Y., Bohr, V. A., Ried, T., Gozani, O., and Chua, K. F. (2008) SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature 452, 492-496
207. Kawahara, T. L. A., Michishita, E., Adler, A. S., Damian, M., Berber, E., Lin, M., McCord, R. A., Ongaigui, K. C., Boxer, L. D., Chang, H. Y., and Chua, K. F. (2009) SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell 136, 62-74
208. Mao, Z., Hine, C., Tian, X., Van Meter, M., Au, M., Vaidya, A., Seluanov, A., and Gorbunova, V. (2011) SIRT6 promotes DNA repair under stress by activating PARP1. Science 332, 1443-1446
209. Gertler, A. A., and Cohen, H. Y. (2013) SIRT6, a protein withmany faces. Biogerontology 14, 629-639
210. Kugel, S., and Mostoslavsky, R. (2014) Chromatin and beyond: the multitasking roles for SIRT6. Trends Biochem. Sci. 39, 72-81
211. Lerrer, B., Gertler, A. A., and Cohen, H. Y. (2016) The complex role of SIRT6 in carcinogenesis. Carcinogenesis 37, 108-118
212. Kanfi, Y., Shalman, R., Peshti, V., Pilosof, S. N., Gozlan, Y. M., Pearson, K. J., Lerrer, B., Moazed, D., Marine, J.C., deCabo, R., and Cohen, H. Y. (2008) Regulation of SIRT6 protein levels by nutrient availability. FEBS Lett. 582, 543-548
213. Zhang, P., Tu, B., Wang, H., Cao, Z., Tang, M., Zhang, C., Gu, B., Li, Z., Wang, L., Yang, Y., Zhao, Y., Wang, H., Luo, J., Deng, C.-X., Gao, B., Roeder, R. G., and Zhu, W.-G. (2014) Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion. Proc. Natl. Acad. Sci. USA 111, 10684-10689
214. Min, L., Ji, Y., Bakiri, L., Qiu, Z., Cen, J., Chen, X., Chen, L., Scheuch, H., Zheng, H., Qin, L., Zatloukal, K., Hui, L., and Wagner, E. F. (2012) Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin. Nat. Cell Biol. 14, 1203-1211
215. Scarpulla, R. C., Vega, R. B., and Kelly, D. P. (2012) Transcriptional integration of mitochondrial biogenesis. Trends Endocrinol. Metab. 23, 459-466
216. Kim, H. S., Xiao, C., Wang, R.H., Lahusen, T., Xu, X., Vassilopoulos, A., Vazquez-Ortiz, G., Jeong, W. I., Park, O., Ki, S. H., Gao, B., and Deng, C. X. (2010) Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis. Cell Metab. 12, 224-236
217. Moschen, A. R., Wieser, V., Gerner, R. R., Bichler, A., Enrich, B., Moser, P., Ebenbichler, C. F., Kaser, S., and Tilg, H. (2013) Adipose tissue and liver expression of SIRT1, 3, and 6 increase after extensive weight loss in morbid obesity. J. Hepatol. 59, 1315-1322
218. Kim, E.-J., and Juhnn, Y.-S. (2015) Cyclic AMP signaling reduces sirtuin 6 expression in non-small cell lung cancer cells by promoting ubiquitin-proteasomal degradation via inhibition of the Raf-MEKERK (Raf/mitogen-activated extracellular signal-regulated kinase/extracellular signal-regulated kinase) pathway. J. Biol. Chem. 290, 9604-9613
219. Kern, P. A., Ranganathan, S., Li, C., Wood, L., and Ranganathan, G. (2001) Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 280, E745-E751
220. Yang, S. J., Choi, J.M., Chae, S. W., Kim, W. J., Park, S. E., Rhee, E. J., Lee, W. Y., Oh, K.W., Park, S. W., Kim, S. W., and Park, C.-Y. (2011) Activation of peroxisome proliferator-activated receptor gamma by rosiglitazone increases sirt6 expression and ameliorates hepatic steatosis in rats. PLoS One 6, e17057
221. Lappas, M. (2012) Anti-inflammatory properties of sirtuin 6 in human umbilical vein endothelial cells. Mediators Inflamm. 2012, 597514
222. Takasaka, N., Araya, J., Hara, H., Ito, S., Kobayashi, K., Kurita, Y., Wakui, H., Yoshii, Y., Yumino, Y., Fujii, S., Minagawa, S., Tsurushige, C., Kojima, J., Numata, T., Shimizu, K., Kawaishi, M., Kaneko, Y., Kamiya, N., Hirano, J., Odaka, M., Morikawa, T., Nishimura, S. L., Nakayama, K., and Kuwano, K. (2014) Autophagy induction by SIRT6 through attenuation of insulin-like growth factor signaling is involved in the regulation of human bronchial epithelial cell senescence. J. Immunol. 192, 958-968
223. Ming, M., Han, W., Zhao, B., Sundaresan, N. R., Deng, C.-X., Gupta, M. P., and He, Y.-Y. (2014) SIRT6 promotes COX-2 expression and acts as an oncogene in skin cancer. Cancer Res. 74, 5925-5933
224. Sharma, A., Diecke, S., Zhang, W. Y., Lan, F., He, C., Mordwinkin, N.M., Chua, K. F., and Wu, J.C. (2013) The role of SIRT6 protein in agingand reprogramming of human induced pluripotentstem cells. J. Biol. Chem. 288, 18439-18447
225. Elhanati, S., Ben-Hamo, R., Kanfi, Y., Varvak, A., Glazz, R., Lerrer, B., Efroni, S., and Cohen, H. Y. (2016) Reciprocal regulation between SIRT6 and miR-122 controls liver metabolism and predicts hepatocarcinoma prognosis. Cell Reports 14, 234-242
226. Wang, Z., Zang, C., Rosenfeld, J. A., Schones, D. E., Barski, A., Cuddapah, S., Cui, K., Roh, T. Y., Peng, W., Zhang, M.Q., and Zhao, K. (2008) Combinatorial patterns of histone acetylations and methylations in the human genome. Nat. Genet. 40, 897-903
227. Seligson, D. B., Horvath, S., McBrian, M. A., Mah, V., Yu, H., Tze, S., Wang, Q., Chia, D., Goodglick, L., and Kurdistani, S. K. (2009) Global levels of histonemodifications predict prognosis in different cancers. Am. J. Pathol. 174, 1619-1628
228. Barber, M. F., Michishita-Kioi, E., Xi, Y., Tasselli, L., Kioi, M., Moqtaderi, Z., Tennen, R. I., Paredes, S., Young, N. L., Chen, K., Struhl, K., Garcia, B. A., Gozani, O., Li, W., and Chua, K. F. (2012) SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation. Nature 487, 114-118
229. Han, Y., Liu, Y., Zhang, H., Wang, T., Diao, R., Jiang, Z., Gui, Y., and Cai, Z. (2013) Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long noncoding RNA MALAT1. FEBS Lett. 587, 3875-3882
230. Kim, J. K., Noh, J. H., Jung, K. H., Eun, J. W., Bae, H. J., Kim, M. G., Chang, Y. G., Shen, Q., Park, W. S., Lee, J. Y., Borlak, J., and Nam, S. W. (2013) Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b. Hepatology 57, 1055-1067
231. Liu, G. F., Lu, J. Y., Zhang, Y. J., Zhang, L. X., Lu, G. D., Xie, Z. J., Cheng, M. B., Shen, Y. F., and Zhang, Y. (2016) C/EBPα negatively regulates SIRT7 expression via recruiting HDAC3 to the upstreampromoter of hepatocellular carcinoma cells. Biochim. Biophys. Acta 1859, 348-354
232. Okada, N., Lin, C. P., Ribeiro, M. C., Biton, A., Lai, G., He, X., Bu, P., Vogel, H., Jablons, D.M., Keller, A.C., Wilkinson, J. E., He, B., Speed, T. P., and He, L. (2014) Apositive feedback betweenp53 andmiR-34 miRNAs mediates tumor suppression. Genes Dev. 28, 438-450
233. Yamakuchi, M., and Lowenstein, C. J. (2009) MiR-34, SIRT1 and p53: the feedback loop. Cell Cycle 8, 712-715
234. Qin, Y., Zhao, J., Min, X., Wang, M., Luo, W., Wu, D., Yan, Q., Li, J., Wu, X., and Zhang, J. (2014) MicroRNA-125b inhibits lens epithelial cell apoptosis by targeting p53 in age-related cataract. Biochim. Biophys. Acta 1842, 2439-2447
235. Kubicka, S., Ku, F., Zender, L., Rudolph, K. L., Manns, M., and Trautwein, C. (1999) p53 Represses CAAT enhancer-binding protein (C/EBP)-dependent transcription of the albumin gene. J. Biol. Chem. 274, 32137-32144
236. Drygin, D., Rice, W.G., and Grummt, I. (2010) The RNApolymerase I transcription machinery: an emerging target for the treatment of cancer. Annu. Rev. Pharmacol. Toxicol. 50, 131-156
237. Grob, A., Roussel, P., Wright, J. E., McStay, B., Hernandez-Verdun, D., and Sirri, V. (2009) Involvement of SIRT7 in resumption of rDNA transcription at the exit from mitosis. J. Cell Sci. 122, 489-498
238. Mohrin, M., Shin, J., Liu, Y., Brown, K., and Luo, H. (2015) A mitochondrial UPR-mediated metabolic checkpoint regulates hematopoietic stem cell aging. Science 347, 1374-1377
239. Vakhrusheva, O., Smolka, C., Gajawada, P., Kostin, S., Boettger, T., Kubin, T., Braun, T., and Bober, E. (2008) Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circ. Res. 102, 703-710
240. Braidy, N., Poljak, A., Grant, R., Jayasena, T., Mansour, H., Chan-Ling, T., Smythe, G., Sachdev, P., and Guillemin, G. J. (2015) Differential expression of sirtuins in the aging rat brain. Front. Cell. Neurosci. 9, 167